Roll Back Malaria

Roll Back Malaria
Name	Roll Back Malaria
Formation	1998
Headquarters	Geneva, Switzerland
Type	Partnership
Region served	Global
Parent organization	World Health Organization

Roll Back Malaria is a global partnership launched in 1998 to coordinate the international response to malaria. It brings together a range of public health actors, multilateral institutions, philanthropic foundations, and national programs to reduce malaria morbidity and mortality. The initiative works across technical, operational, and policy domains to align strategies of major stakeholders and mobilize resources for endemic countries.

Background and Origins

Roll Back Malaria emerged from dialogues involving World Health Organization, United Nations Children's Fund, World Bank, and member states responding to the resurgence of malaria in the 1990s. Influential conferences and agreements such as the Alma-Ata Declaration and later meetings in Geneva informed the shift from vertical campaigns to integrated programming, drawing lessons from campaigns like the Global Malaria Eradication Programme and regional efforts in Sub-Saharan Africa and Southeast Asia. Key actors at the outset included bilateral donors such as United States Agency for International Development, Department for International Development (UK), and multilateral funds including the Global Fund to Fight AIDS, Tuberculosis and Malaria, alongside advocacy from philanthropies such as the Bill & Melinda Gates Foundation.

Governance and Partnerships

The governance architecture incorporates agencies like World Health Organization, United Nations Development Programme, United Nations Children's Fund, and World Bank alongside non-state actors including Clinton Health Access Initiative, Médecins Sans Frontières, PATH (organization), and Malaria No More. National malaria control programs from countries such as Nigeria, Democratic Republic of the Congo, India, Brazil, and Papua New Guinea participate. The partnership interfaces with global policy bodies like the Gavi, the Vaccine Alliance, the Intergovernmental Panel on Climate Change, and academic centers including London School of Hygiene & Tropical Medicine, Harvard T.H. Chan School of Public Health, and University of Oxford. Regional economic communities such as the African Union and technical networks like the Roll Back Malaria Partnership to End Malaria constituency facilitate coordination with private sector partners including GlaxoSmithKline, Novartis, and diagnostic firms involved with World Health Organization prequalification.

Strategy and Interventions

RBM’s strategic framework emphasizes evidence-based tools including long-lasting insecticidal nets distributed in mass campaigns similar to approaches used by United States President's Malaria Initiative, indoor residual spraying modeled after programs from South Africa and Swaziland (Eswatini), and prompt case management following protocols developed through World Health Organization guidelines. Chemoprevention strategies draw on research from institutes such as Institut Pasteur, Centers for Disease Control and Prevention, and Mahidol University. Vaccine efforts coordinate with trials at Walter Reed Army Institute of Research, the Ifakara Health Institute, and partnerships with Gavi, the Vaccine Alliance and Bill & Melinda Gates Foundation to advance candidates like the RTS,S vaccine evaluated in phase III studies in countries including Ghana, Kenya, and Mozambique.

Funding and Resource Mobilization

Resource mobilization leverages contributions from multilateral institutions such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, bilateral donors like United States Agency for International Development and Department for International Development (UK), and philanthropic funders including the Bill & Melinda Gates Foundation and Wellcome Trust. Financial architecture involves treasury relationships with World Bank instruments, innovative financing dialogues with International monetary fund stakeholders, and private sector engagement with corporations such as Unilever and Cargill for commodity supply chains. Country co-financing aligns with fiscal planning at ministries in Ethiopia, Uganda, and Rwanda and budget support mechanisms used in partnerships with European Commission development programs.

Implementation and Country Programs

Country-level implementation is organized through national malaria control programs in coordination with Ministry of Health (Nigeria), Ministry of Health (Kenya), and equivalent agencies in Tanzania, Ghana, and Cameroon. Operational partners include MSF, Red Cross, and community-health worker models informed by programs in Ethiopia and Bangladesh. Surveillance systems integrate platforms such as the District Health Information Software 2 used across Africa, and entomological monitoring collaborates with institutions like KEMRI–Wellcome Trust Research Programme and Institut Pasteur de Madagascar. Supply chain logistics draw on expertise from UNICEF procurement and private logistics firms operating in Nairobi and Johannesburg hubs.

Impact and Outcomes

Roll Back Malaria and allied efforts contributed to reductions in malaria incidence and mortality documented by World Health Organization World Malaria Reports and epidemiological analyses from Lancet and New England Journal of Medicine articles. Notable country successes occurred in Zambia, Rwanda, and Eritrea alongside localized elimination advances in Sri Lanka and Morocco. Research collaborations with Wellcome Trust and Centers for Disease Control and Prevention produced evidence on insecticide-treated net effectiveness and resistance patterns described in journals such as Nature and Science. Global targets referenced in Sustainable Development Goals shaped metric reporting and accountability frameworks.

Challenges and Future Directions

Persistent challenges include insecticide resistance monitored by networks including Insecticide Resistance Action Committee and antimalarial drug resistance tracking linked to institutes like Wellcome Sanger Institute and Mahidol–Oxford Tropical Medicine Research Unit. Climate change implications studied by Intergovernmental Panel on Climate Change affect transmission dynamics in regions including Sahel and Horn of Africa. Vaccine deployment, surveillance strengthening, health systems integration with Primary Health Care reforms drawing on WHO guidance, and financing sustainability amid competing priorities from agencies like Global Fund to Fight AIDS, Tuberculosis and Malaria and bilateral donors remain central. Future directions involve partnerships with genomic research centers like Broad Institute, novel vector control trials with entities such as Oxitec, and greater alignment with continental initiatives led by African Union and regional economic communities.

Category:Global health initiatives